文献速递糖尿病

1型糖尿病患者的快速糖化表型、皮肤晚期糖基化终产物与并发症负担

The Fast-Glycator Phenotype, Skin Advanced Glycation End Products, and Complication Burden Among People With Type 1 Diabetes.
PubMed 文献 · Diabetes Care · 2022-01-01

研究纳入135例使用间歇扫描式连续葡萄糖监测至少90天且观察终点有实验室HbA1c的1型糖尿病患者,以葡萄糖管理指标与HbA1c比值<0.9定义快速糖化表型。22.2%患者存在该表型,其皮肤自发荧光更高且大血管病变、白蛋白尿、视网膜病变患病率更高;调整年龄和血脂异常后,快速糖化表型仍与大血管病变独立相关(OR 3.72,95%CI 1.22-11.4)。

要点

  • 22.2%的1型糖尿病患者存在快速糖化表型(GMI/HbA1c比值<0.9)。
  • 快速糖化者皮肤AGEs更高(SAF 2.5 vs 2.1任意单位,P=0.005)。
  • 调整年龄和血脂异常后,快速糖化表型仍与大血管病变相关(OR 3.72,95%CI 1.22-11.4)。

核心结论

  • 在1型糖尿病中,以GMI与HbA1c比值定义的快速糖化表型以皮肤AGEs升高为特征,并与并发症负担相关。

研究设计与样本

  • 研究纳入135例1型糖尿病患者(58%为男性;平均年龄44.4岁),连续使用间歇扫描式连续葡萄糖监测系统至少90天,并在观察终点有实验室检测的HbA1c。
  • 皮肤AGEs采用皮肤自发荧光(SAF)法评估,并发症负担通过标准化筛查评估。
  • 快速糖化表型定义为GMI与HbA1c比值<0.9。

主要发现

  • 135例患者平均糖尿病病程21年,平均HbA1c为7.7%;30例(22.2%)被定义为快速糖化表型。
  • 快速糖化者HbA1c更高(8.6% vs 7.5%;P<0.001),但90天平均血糖水平相似(172 vs 168 mg/dL;P=0.52)。
  • 快速糖化者SAF高于其他参与者(2.5 vs 2.1任意单位;P=0.005)。
  • 快速糖化者血脂异常患病率(73% vs 44%;P=0.005)、大血管病变(38% vs 9%;P=0.001)、白蛋白尿(25% vs 7%;P=0.038)和视网膜病变(61% vs 38%;P=0.022)均显著更高。
  • 调整年龄和血脂异常后,快速糖化表型仍与大血管病变显著相关(OR 3.72;95%CI 1.22-11.4)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Existence of a fast-glycator phenotype among people with type 1 diabetes (T1D) is debated. Routine use of glucose sensors allows the comparison of long-term average glucose levels with laboratory HbA1c values. We herein evaluated whether participants with T1D and HbA1c values higher than their glucose management indicator (GMI) had greater accumulation of advanced glycation end products (AGEs) and chronic complications. RESEARCH DESIGN AND METHODS: We included participants with T1D using the intermittently scanned continuous glucose monitoring system consecutively for at least 90 days and having a laboratory-determined HbA1c at the end of observation. Skin AGEs were estimated using the skin autofluorescence (SAF) method. The complication burden was assessed by a standardized screening. The fast-glycator phenotype was defined as having a GMI to HbA1c ratio <0.9. RESULTS: We included 135 individuals with T1D (58% men; mean age, 44.4 years) with a mean diabetes duration of 21 years and a mean HbA1c value of 7.7%. Thirty (22.2%) were defined as having the fast-glycator phenotype. As expected, fast glycators had higher HbA1c (8.6% vs. 7.5%; P < 0.001) with similar 90-day mean glucose level (172 vs. 168 mg/dL; P = 0.52). Fast glycators had higher SAF than did other participants (2.5 vs. 2.1 arbitrary units; P = 0.005) and had a significantly higher prevalence of dyslipidemia (73% vs. 44%; P = 0.005), macroangiopathy (38% vs. 9%; P = 0.001), albuminuria (25% vs. 7%; P = 0.038), and retinopathy (61% vs. 38%; P = 0.022). After adjusting for age and dyslipidemia, the fast-glycator phenotype remained significantly associated with macroangiopathy (odds ratio 3.72; 95% CI 1.22-11.4). CONCLUSIONS: In T1D, a fast-glycator phenotype defined by the GMI to HbA1c ratio is characterized by elevated skin AGEs and is associated with the complication burden.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Maran A, Morieri ML, Falaguasta D, et al. The Fast-Glycator Phenotype, Skin Advanced Glycation End Products, and Complication Burden Among People With Type 1 Diabetes. Diabetes Care. 2022. PMID: 35972256. doi:10.2337/dc22-0980

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。